FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/12/2024
Back to search
Official data from USPTO
ZEMCELPRO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ZEMCELPRO
ST13
US500000079362170Class
5, 44
Filing
79362170
Registration
7307475
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
10/12/2024
Trademark type
Word
Nice classes
5, 44
Filing date
11/30/2022
Registration date
02/20/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/20/2024
Last transaction
02/20/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CA
Examiner
MARCY, AMY
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CORDEX BIOLOGICS INC.
EXCELLTHERA INC.
Representatives
Amanda Roach GREENSFELDER, HEMKER & GALE, P.C.
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and biological preparations for medical usefor the prevention and treatment of diseases and disorders of the immune system and the musculo-skeletal system; pharmaceutical and biological preparations for medical usefor use in oncologyhematology and in tissue and organ transplantation; pharmaceutical and biological preparations for medical usefor the prevention and treatment of autoimmune diseases and disorders
Class 44
Collection and preservation of biological tissueblood and cells; medical diagnostic services; medical treatment of cancers and hematologicalauto-immunegenetic and rare diseases provided by clinics and hospitals; provision of medical information and data for diagnosis and medical treatment in the field of cell therapy and cancer treatment
Publications
History of USPTO decisions and trademark events.
27 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
08/07/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
08/07/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/21/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/20/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/05/2023
PUBO
PUBLISHED FOR OPPOSITION
12/05/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/15/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/15/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/31/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/30/2023
RFNT
REFUSAL PROCESSED BY IB
10/17/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/26/2023
RFRR
REFUSAL PROCESSED BY MPU
09/26/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/10/2023
CNRT
NON-FINAL ACTION WRITTEN
09/09/2023
DOCK
ASSIGNED TO EXAMINER
09/09/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/10/2023
CHLD
CHANGE OF OWNER RECEIVED FROM IB
05/27/2023
MAFR
APPLICATION FILING RECEIPT MAILED
02/14/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/10/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/09/2023
Continuous trademark protection
Get notified about every new filing that threatens ZEMCELPRO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.